Form 4 for CNMD CONMED Corp
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-02 · accession 0001127602-22-003422 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-04 | 2022-02-02 | CNMD | CONCANNON BRIAN | Dir | F - Tax | $139.03 | -928 | 11.1K | -8% | -$129.0K |
| DM | 2022-02-04 | 2022-02-02 | CNMD | CONCANNON BRIAN | Dir | S - Sale+OE | $135.73 | -13.0K | 9,000 | -59% | -$1.76M |
| DM | 2022-02-04 | 2022-02-02 | CNMD | CONCANNON BRIAN | Dir | M - OptEx | $64.25 | +9,557 | 11.2K | +594% | +$614.1K |
| DM | 2022-02-04 | 2022-02-02 | CNMD | CONCANNON BRIAN | Dir | M - OptEx | $0.00 | -9,557 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-02 | F | D | 241 | $139.03 | 9,759 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-02 | S | D | 1,843 | $135.06 | 9,000 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2022-02-02 | M | A | 1,843 | $73.94 | 10,843 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-02 | M | A | 1,000 | $33.43 | 10,000 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-02 | M | A | 1,000 | $39.64 | 10,759 | D | — | — | |
| 6 | Common | Common Stock | 2022-02-02 | F | D | 286 | $139.03 | 10,473 | D | — | — | |
| 7 | Common | Common Stock | 2022-02-02 | M | A | 1,000 | $55.70 | 11,473 | D | — | — | |
| 8 | Common | Common Stock | 2022-02-02 | F | D | 401 | $139.03 | 11,072 | D | — | — | |
| 9 | Common | Common Stock | 2022-02-02 | S | D | 2,027 | $135.09 | 13,400 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 10 | Common | Common Stock | 2022-02-02 | S | D | 4,200 | $136.96 | 9,200 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 11 | Common | Common Stock | 2022-02-02 | S | D | 200 | $137.91 | 9,000 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 12 | Common | Common Stock | 2022-02-02 | M | A | 2,549 | $69.03 | 11,549 | D | — | — | |
| 13 | Common | Common Stock | 2022-02-02 | S | D | 2,549 | $135.08 | 9,000 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 14 | Common | Common Stock | 2022-02-02 | M | A | 2,165 | $79.94 | 11,165 | D | — | — | |
| 15 | Common | Common Stock | 2022-02-02 | S | D | 2,165 | $135.08 | 9,000 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 16 | Derivative | Options To Purchase Common Stock | 2022-02-02 | M | D | 1,843 | $0.00 | 0 | D | $73.94 · 2021-06-01 to 2030-06-01 | 1,843 Common Stock | (F8) The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| 17 | Derivative | Sars (Stock Appreciation Rights) | 2022-02-02 | M | D | 1,000 | $0.00 | 0 | D | $55.70 · 2016-06-01 to 2025-06-01 | 1,000 Common Stock | |
| 18 | Derivative | Sars (Stock Appreciation Rights) | 2022-02-02 | M | D | 1,000 | $0.00 | 0 | D | $39.64 · 2015-06-01 to 2024-09-11 | 1,000 Common Stock | (F10) The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. |
| 19 | Derivative | Sars (Stock Appreciation Rights) | 2022-02-02 | M | D | 1,000 | $0.00 | 0 | D | $33.43 · 2014-06-01 to 2023-07-26 | 1,000 Common Stock | (F9) The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. |
| 20 | Derivative | Options To Purchase Common Stock | 2022-02-02 | M | D | 2,165 | $0.00 | 0 | D | $79.94 · 2020-06-01 to 2029-06-03 | 2,165 Common Stock | (F7) The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| 21 | Derivative | Options To Purchase Common Stock | 2022-02-02 | M | D | 2,549 | $0.00 | 0 | D | $69.03 · 2019-06-01 to 2028-06-01 | 2,549 Common Stock | (F7) The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |